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IGF-1 mediated Neurogenesis 
Involves a Novel RIT1/Akt/Sox2 
Cascade
Sajad Mir1, Weikang Cai1,2, Shaun W. Carlson3,4, Kathryn E. Saatman3 & Douglas A. Andres1
Insulin-like growth factor 1 (IGF-1) is known to have diverse effects on brain structure and function, 
including the promotion of stem cell proliferation and neurogenesis in the adult dentate gyrus. 
However, the intracellular pathways downstream of the IGF-1 receptor that contribute to these 
diverse physiological actions remain relatively uncharacterized. Here, we demonstrate that the Ras-
related GTPase, RIT1, plays a critical role in IGF-1-dependent neurogenesis. Studies in hippocampal 
neuronal precursor cells (HNPCs) demonstrate that IGF-1 stimulates a RIT1-dependent increase in 
Sox2 levels, resulting in pro-neural gene expression and increased cellular proliferation. In this novel 
cascade, RIT1 stimulates Akt-dependent phosphorylation of Sox2 at T118, leading to its stabilization 
and transcriptional activation. When compared to wild-type HNPCs, RIT1−/− HNPCs show deficient 
IGF-1-dependent Akt signaling and neuronal differentiation, and accordingly, Sox2-dependent 
hippocampal neurogenesis is significantly blunted following IGF-1 infusion in knockout (RIT1−/−) mice. 
Consistent with a role for RIT1 function in the modulation of activity-dependent plasticity, exercise-
mediated potentiation of hippocampal neurogenesis is also diminished in RIT1−/− mice. Taken together, 
these data identify the previously uncharacterized IGF1-RIT1-Akt-Sox2 signaling pathway as a key 
component of neurogenic niche sensing, contributing to the regulation of neural stem cell homeostasis.
Adult neurogenesis is a dynamic process in which new neurons are generated from neural stem/progenitor cells 
(NPCs) through the carefully orchestrated regulation of proliferation and neuronal fate determination. Adult 
born neurons have the ability to functionally integrate into the hippocampal circuitry and have been found to 
contribute to select types of hippocampal-dependent learning and memory tasks1. A critical feature of adult neu-
rogenesis is its regulation by diverse physiological, pathological, and pharmacological stimuli, including exercise, 
aging, traumatic brain injury, epilepsy, and antidepressants2. NPCs are normally quiescent, but once activated 
are capable for self-renewal to maintain the neural stem cell population and to produce dividing progenitors 
capable of differentiating into neurons3–5. Significantly, the maintenance and proliferation of adult NPCs, and 
the differentiation, migration, and maturation of adult born neurons, are known to be regulated by extracellular 
growth factor signaling pathways6, 7. Growth factor signaling is known to control a variety of intracellular reg-
ulatory mechanisms within NPCs, including transcription factors and epigenetic regulators that serve to finely 
coordinate gene expression during neurogenesis2. For example, the transcription factor Sex-determining region Y 
related HMG box 2 (Sox2) has well-established roles in maintaining stem cell/progenitor cell properties in diverse 
cellular populations8, 9, including neuronal stem cell self-renewal and neurogenesis10.
Insulin-like growth factor-1 (IGF-1) signaling has been implicated in the regulation of adult neurogenesis11–13. 
For example, conditional deletion of the IGF-1 receptor gene (Igf1r) results in an almost complete loss of the 
dentate gyrus (DG) in mice14 while exogenous IGF-1 promotes enhanced HNPC proliferation15, 16, and directs 
the generation of mature granule cells15–18. These effects rely on the ability of activated IGF-1R to activate diverse 
intracellular regulatory cascades, including the ERK MAP kinase and PI3-kinase/Akt pathways19, 20. In particu-
lar, Akt signaling has been reported to play a central role in IGF-1-mediated HNPC proliferation and neuronal 
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differentiation21–24. IGF-1/Akt signaling is also known to control neuronal transcription factor activity22, 25, how-
ever the nature of the specific transcriptional pathway(s) involved in IGF-1 dependent neural stem cell activation 
remain incompletely characterized.
Running is a particularly potent instigator of hippocampal neurogenesis with evidence from human and ani-
mal research indicating that exercise improves hippocampal function, synaptic plasticity, learning, and modu-
lates depression26. Lineage tracing studies27 have demonstrated that voluntary exercise increases the number of 
Sox2+ neural stem cells in the DG, and importantly, pharmacological inhibition of Akt has been found to inhibit 
exercise-mediated enhancement of adult hippocampal neurogenesis28, 29. Since, exercise increases the availability 
of several classes of growth factors, including IGF-130, this work suggests a link between physiological/growth 
factor cues, Akt signaling, and the regulation of neurogenesis. The discovery of signaling pathways that enhance 
adult neurogenesis may lead to therapeutic strategies for improved memory function due to aging or following 
injury. Therefore, it is important to develop a detailed molecular understanding of these cascades.
The Ras-related GTPase, RIT1, is expressed throughout the central nervous system and within the developing 
brain31–33. Despite its widespread expression, RIT1 function remains incompletely characterized34. We have pre-
viously demonstrated that RIT1 serves as a central regulator of stress-activated MAPK activity and pro-survival 
signaling35. In keeping with a role in directing survival signaling, adult born immature neurons lacking RIT1 
display significantly increased rates of trauma-induced loss following contusive brain injury36. Surprisingly, RIT1 
knockout (RIT1−/−) mice also exhibit a significant delay in the innate restoration of neurogenesis following brain 
injury36, suggesting that RIT1 controlled signaling contributes to the period of enhanced hippocampal neuro-
genesis observed following brain insult37. More recently we identified somatic RIT1 mutations in a subset of 
human lung adenocarcinomas, and found that ectopic expression of mutated RIT1 in cell culture activates Akt 
signaling and promotes cellular transformation38. Importantly, expression of oncogenic RIT1 also stimulates the 
Akt-dependent proliferation of HNPCs39. Here, we demonstrate the physiological importance of RIT1 function 
by establishing a role for RIT1 in both IGF-1 dependent control, and exercise-enhanced stimulation, of hip-
pocampal neurogenesis. Using in vivo and in vitro genetic strategies to manipulate RIT1 function, we find that 
IGF-1 stimulates a RIT1-Akt-Sox2 signal transduction cascade in HNPCs that leads to increased neurogenesis. 
In this pathway, RIT1-Akt activity results in phosphorylation of Sox2 at T118, to increase Sox2 transcriptional 
activity, enabling IGF-1 directed activation of the neurogenic program.
Results
Loss of RIT1 alters exercise-induced neurogenesis. We have shown that RIT1 deficiency alters hip-
pocampal neurogenesis following traumatic brain injury by delaying the post-concussive recovery of immature 
neurons without affecting basal rates of neurogenesis36. However, whether RIT1 contributes to the regulation of 
adult neurogenesis more broadly in response to physiological stimuli is unknown. Importantly, RIT1 is known to 
be expressed in HNPCs, supporting a potential role for RIT1 in the regulation of neural progenitor function39. To 
assess the role of RIT1 in voluntary exercise-enhanced hippocampal neurogenesis40, RIT1 knockout (RIT1−/−) 
(n = 17) and wild-type (n = 23) mice were randomly assigned to either sedentary or running groups (running 
wheels were preinstalled in the housing cages permitting voluntary exercise), and the impact of RIT1 loss on 
exercise-enhanced neurogenesis assessed at either day 16 or 42 (Fig. 1A). Both wild-type and RIT1−/− mice in 
the runner groups ran an average distance of ~10 kilometers a day with no inherent difference arising from RIT1 
deficiency (wild-type: 10.25 ± 1.14 km/d; RIT1−/−: 10.10 ± 0.59 km/d, p = 0.86, n = 3). During the trial, mice 
received one daily intraperitoneal BrdU injection (50 mg/kg) for the first 2 weeks, to label proliferating neuro-
blasts (BrdU+/DCX+ cells) (analysis day 16) (Fig. 1B) and maturing neurons (analysis day 42; 1 month post-BrdU 
chase) (BrdU+/NeuN+) (Fig. 1C). While lineage tracing detected approximately equivalent numbers of BrdU 
labeled proliferating neuroblasts (p > 0.05) and mature neurons (p > 0.05) in sedentary housed mice (p > 0.05), 
RIT1−/− mice displayed a significantly lower density of proliferating neuroblasts (*p < 0.01), and neurons that 
matured from these neuroblasts following running exercise than wild-type controls (*p = 0.01) (Fig. 1D,E). These 
data suggest that RIT1 signaling contributes to the proliferation and neuronal differentiation following voluntary 
exercise.
RIT1 contributes to IGF-1 dependent neurogenesis. Running exercise increases the availability of 
several classes of growth factor, including BDNF and IGF-1, which have known roles in regulating adult neu-
rogenesis30. While RIT1 plays a role downstream of diverse mitogen-activated receptors34, we have previously 
shown that BDNF signaling in primary hippocampal neuron cultures is not altered by RIT1 deficiency36. In 
agreement with earlier in vitro studies41, IGF-1 exposure (100 ng/ml, 15 min) led to robust ERK and Akt activation 
in wild-type hippocampal cultures (Fig. 2A). Importantly the activation of both kinases was blunted (~55% of 
kinase phosphorylation of WT hippocampal neuronal cultures, n = 3, p < 0.05) in RIT1−/− cultures as monitored 
by anti-phospho-specific immunoblotting (Fig. 2A). Consistent with a role for RIT1 in IGF-1 signaling, wild-type 
primary hippocampal neural progenitor cells (HNPCs) (Fig. 2B) displayed increased proliferation (p < 0.01) fol-
lowing IGF-1 exposure (Fig. 2C,F), while RIT1−/− HNPCs failed to respond (p > 0.05) (Fig. 2E,G), as assessed by 
confocal microscopy (co-stained Nestin+/Ki67+ cells). Expression of Myc-tagged RIT1 rescued IGF-1 dependent 
proliferation in RIT1−/− HNPCs (p < 0.05) (Fig. 2D,E and G). These data suggest that RIT1 plays a key role in 
IGF-1 signaling and contributes to HNPC proliferation in vitro.
We next asked whether RIT1 signaling contributes to IGF-1-dependent in vivo stimulation of hippocampal 
neurogenesis15. In agreement with previous studies15, 16, 18, peripheral infusion of exogenous recombinant IGF-1 
(500 ng/kg/day) (Fig. 3A) was found to induce neurogenesis in the mouse hippocampus (Fig. 3B). Using BrdU 
labeling, we found a significant increase in newborn BrdU+/DCX+ immature neurons in the dentate granule cell 
layer of the hippocampus of WT mice after 7 d of peripheral IGF-1 administration, when compared to vehicle 
controls (Fig. 3B,C). While vehicle treated WT and RIT1−/− mice displayed similar numbers of BrdU+/DCX+ 
www.nature.com/scientificreports/
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newborn immature neurons, IGF-1 dependent progenitor cell proliferation was significantly blunted in the den-
tate of RIT1−/− mice (Fig. 3B,C) (p < 0.05). Taken together, both in vivo and in vitro data indicate that RIT1 plays 
a critical role in IGF-1 induced neurogenesis.
IGF-1 regulates neurogenic transcription factor expression in HNPCs. IGF-1 has been shown to 
direct the differentiation of hippocampal NPCs to mature granule neurons17, and IGF-1 treatment of wild-type 
HNPC cultures significantly increased the number of Tuj1+ neurons (Fig. 4A,C) (p < 0.05). In keeping with a 
central role for RIT1 in IGF-1 signaling, the ability of IGF-1 to stimulate HNPC neuronal induction was signifi-
cantly blunted following RNAi-mediated RIT1 silencing (Fig. 4A,C and E), resulting in significantly fewer Tuj1+ 
neurons when compared with HNPC cultures treated with control RNAi (p < 0.05). Similar results were seen 
in cultured RIT1−/− HNPCs, in which IGF-1 stimulation failed to promote the robust neuronal differentiation 
observed in WT cultures (Fig. 4B,D). Importantly, the neurogenic deficit in RIT1−/− HNPCs could be rescued by 
re-expression of Myc-tagged RIT1 (Fig. 4B and D) (p < 0.05).
Figure 1. Adult neurogenesis in RIT1−/− and WT littermates housed under running conditions. (A) 
Schematic of experimental design (see methods for details). WT and RIT1−/− mice were injected daily with 
BrdU (50 mg/kg, i.p) for 14 days while housed in either sedentary or running cages and either analyzed for 
newborn neuroblasts (DCX+/BrdU+) (day 16) or the generation of mature neurons (NeuN+/BrdU+) (day 42). 
Representative coronal hippocampal sections from the dentate gyrus of (B) 16d mice immunostained for DCX 
(white, pseudocolor), BrdU (red, white arrowheads) and DAPI, or (C) 42d mice co-immunostained with NeuN 
(green) and BrdU (red; white arrowheads). The inserts are at higher magnification. The arrow heads indicate 
either newborn neuroblasts (B) or mature neurons (C). Scale bar, 20 μm. (D) Quantitative analysis of newborn 
immature hippocampal neurons (BrdU+/DCX+) following 16 days of running or sedentary housing (*p < 0.01, 
two-way ANOVA). (E) Quantitative analysis of BrdU+ mature neurons (NeuN+) at day 42 (*p < 0.01, two-way 
ANOVA). The results are presented as mean ± SEM (WT, n = 17; RIT1−/−, n = 23).
www.nature.com/scientificreports/
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Adult neurogenesis involves the activation of a multistep transcriptional network42 including the sequential 
expression of Ascl143 and NeuroD144, 45 transcription factors. To determine whether IGF-1 stimulation of HNPCs 
results in the activation of this transcriptional cascade, we used immunohistochemical analysis to determine 
the effect of IGF-1 on Ascl1 and NeuroD1 expression in HNPCs. As seen in Fig. 5, IGF-1 stimulation of HNPCs 
(50 ng/ml IGF-1, 24 h) resulted in a prominent increase in both Ascl1 (Fig. 5A and C) and NeuroD1 (Fig. 5B and 
D) expressing HNPCs. Consistent with a role for RIT1 in this process, IGF-1 stimulation failed to significantly 
increase levels of either Ascl1 or NeuroD1 in RIT1−/− HNPCs (Fig. 5E–H) (p > 0.05), but importantly, Myc-RIT1 
re-expression was capable of restoring IGF-1-dependent increases in both transcription factors (Fig. 5E–H) 
(p < 0.05). Consistent with these data, RT-PCR analysis demonstrates that IGF-1 stimulation leads to an increase 
in the expression of both NeuroD1 and Ascl1, in a manner that depends upon RIT1 (Fig. 5I). Furthermore, 
immunoblotting demonstrates a RIT1-dependent increase in Ascl1 protein levels following IGF-1 (20 ng/ml) 
stimulation in HNPCs (Fig. 5J). Thus, RIT1 deficiency blunts IGF-1-dependent regulation of pro-neurogenic 
gene expression and neural differentiation of HNPCs.
IGF-1 regulates SOX2 stability and transcriptional activity in HNPCs. Recent work has shown that 
the transcription factor SRY (sex determining region Y)-box 2 (SOX2), is expressed by adult NSCs, and required 
Figure 2. RIT1 loss disrupts IGF-1-mediated in vitro HNPC proliferation. (A) Lysates from cultured WT 
and RIT1−/− HNPC cultures were analyzed by immunoblotting with the indicated antibodies following IGF-1 
stimulation (100 ng/ml; 15 min). Representative images were cropped from the original blots run in parallel. 
(B) Phase contrast and immunocytochemical detection of Nestin (green) and DAPI (blue) of neurospheres 
clonally expanded from the dentate gyrus of wild-type mice. (C) Proliferation of WT HNPCs was assessed 
by immunocytochemical detection of Nestin (green) and Ki67 (red) 24 h following stimulation with or 
without IGF-1 (50 ng/ml). Scale bar, 15 μm. (D) Representative confocal images of transfected Myc-tagged 
RIT1 (red) expression in dissociated WT HNPCs. Scale bar, 10 μm. (E) Transfected RIT1−/− HNPCs (Myc-
tagged RIT1 or empty vector) were left untreated or stimulated with IGF-1 (50 ng/ml) and proliferation was 
assessed at 24 h by immunohistochemical detection of Nestin (green) and Ki67 (red). Scale bar, 15 μm. (F,G) 
Quantification of IGF-1 mediated HNPC proliferation (Nestin+/Ki67+)/200 cells counted from 5–6 fields in 
WT (*p < 0.05 nonparametric one tailed t-test), RIT1−/−, and following re-expression of Myc-RIT1 in RIT1−/− 
HNPCs (*p < 0.05, one-way ANOVA). Results are presented as mean ± SEM calculated from three separate 
experiments.
www.nature.com/scientificreports/
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both for the maintenance of NPC pluripotency and in establishing the epigenetic state required for neuronal 
differentiation in response to neurogenic cues46. We have recently found that constitutively activate RIT1 is capa-
ble of stimulating SOX2-dependent gene expression39. To evaluate whether RIT1-SOX2 signaling contributes to 
IGF-1-dependent neurogenesis, we analyzed the effect of IGF-1 on SOX2 protein levels in HNPCs. As seen in 
Fig. 6, IGF-1 (50 ng/ml, 24 hrs) stimulation of wild-type HNPCs resulted in a prominent increase in SOX2+ cells 
(p < 0.05) (Fig. 6A,E), and SOX2 protein levels (Fig. 6C). RNAi-dependent RIT1 silencing blunted the IGF-1 
mediated increase in SOX2 protein levels (Fig. 6A,E) (p < 0.05). A similar result was seen in IGF-1 stimulated 
RIT1−/− HNPCs (Fig. 6B,D,F), with re-expression of RIT1 capable of restoring the IGF-1-dependent increase in 
SOX2 levels (Fig. 6B,D,F) (p < 0.05). Importantly, robust SOX2 transcriptional activity was observed in wild-type 
HNPCs following IGF-1 stimulation (50 ng/ml) (p < 0.01), but failed to induce SOX2 reporter activity in HNPCs 
following RNAi-mediated RIT1 silencing (Fig. 6G). Similar results were seen in RIT1−/− HNPCs with the deficit 
in SOX2 transcriptional activity rescued by re-expression of wild-type RIT1 (p < 0.1) (Fig. 6H). Taken together, 
these data suggest that IGF-1-dependent hippocampal neurogenesis involves a RIT1-SOX2 signaling cascade.
IGF-1/RIT1/Akt-dependent SOX2-T118 phosphorylation during neuronal induction. Recent 
studies have found that SOX2 is regulated by a methylation-phosphorylation switch, in which phosphorylation 
at T118 stabilizes the SOX2 protein and enhances its transcriptional activity in embryonic stem cells47. Whether 
a similar mechanism operates to control SOX2 during hippocampal neurogenesis is unknown, but since neural 
expression of active RIT1 promotes SOX2-T118 phosphorylation39, we hypothesized that this cascade contrib-
utes to IGF-1 dependent SOX2 activation in HNPCs. In support of this notion, we observed IGF-1-dependent 
stimulation of Akt activity in wild-type HNPCs, as detected by phospho-specific AktS473 immunofluorescence 
(Fig. 7A,C) (p < 0.01). In agreement with our earlier data (Fig. 2A), RIT1−/− HNPCs displayed blunted Akt acti-
vation (Fig. 7B,D) (p < 0.01) which could be rescued by RIT1 re-expression (Fig. 7B,D). Western blotting found 
that IGF-1 exposure dramatically increased the phosphorylation of SOX2 at T118 while the phosphorylation 
at Ser25/Ser251 was unaffected (Fig. 8A). Confocal laser scanning microscopy also showed higher number of 
phospho-SOX2-T118+ nuclei in wild-type HNPCs (Fig. 8B,D) (p < 0.05). Pharmacological blockade of Akt sig-
naling with Triciribine48 inhibited the number of phospho- SOX2-T118+ nuclei following IGF-1 stimulation 
(Fig. 8B,D). IGF-1-dependent SOX2-T118 phosphorylation was also blunted in RIT1−/− HNPCs, and this deficit 
Figure 3. RIT1 deficiency impairs IGF-1-dependent adult neurogenesis. (A) WT and RIT1−/− mice (n = 10 
per genotype) were continuously administered either rhIGF-1 (500 ng/kg/day) or vehicle via subcutaneous 
pump infusion for 1 week. At day 3 of infusion, mice were i.p. injected with BrdU (50 mg/kg) (×4) over 12 h. 
(B) Representative coronal hippocampal sections co-immunostained for BrdU (red) and DCX (white) (Scale 
bar 20 μm). The inserts are at higher magnification. Arrowheads (white) indicate newborn DCX+/BrdU+ 
neuroblasts. (C) Quantification of the BrdU+/DCX+ proliferating neuroblast density (cell counts/mm3) 
within the dentate gyrus of WT and RIT1−/− mice (*p < 0.01, one-way ANOVA). Results are presented as 
mean ± SEM.
www.nature.com/scientificreports/
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could be complemented by expression of exogenous RIT1 (Fig. 8C,E). The loss of SOX2 in adult HNPCs has been 
shown to decrease the expression of pro-neural genes, compromising the differentiation of newborn neurons46. 
Importantly, Akt inhibition significantly reduced the number of Tuj1+ neurons in IGF-1 treated HNPC cultures 
(Fig. 8F,G) (p < 0.01). Taken together, these data indicate that IGF-1 directs a downstream RIT1-Akt-SOX2 sign-
aling cascade to regulate neurogenesis (Fig. 8H).
Discussion
Studies in the mammalian central nervous system support an essential role for insulin and insulin-like growth 
factors in stem cell self-renewal, neurogenesis, and cognitive function through distinct ligand-mediated recep-
tor activation cascades13. Although IGF-1 has long been associated with the regulation of neural stem cell biol-
ogy, and much is known about the diversity of IGF-1-dependent signaling cascades19, mechanisms by which 
IGF-1 governs neurogenesis remain incompletely characterized. Here, we provide evidence for the involvement 
of RIT1 as a critical downstream component of IGF-1-dependent, and exercise-mediated enhancement, of hip-
pocampal neurogenesis. We demonstrate that, IGF-1 regulates Sox2 activation and neuronal differentiation in a 
RIT1-dependent fashion in HNPCs, with RIT1 directing IGF-1-mediated expression of the pro-neuronal Ascl1 
and NeuroD1 genes, and Akt-dependent up-regulation of Sox2 transcriptional activity. Thus, we demonstrate that 
RIT1/Akt signaling plays a crucial role in IGF-1 dependent neural cell fate selection by controlling Sox2 function.
During both CNS development and adult neurogenesis, IGF-1/IGF-1R signaling has been found to regulate 
the proliferation and survival of neuronal progenitors as well as the generation, differentiation, and maturation 
of neurons11, 12, 18, 49–51. Circulating IGF-1 has been implicated in the beneficial effects of exercise on brain func-
tion, including increased hippocampal neurogenesis15, 52. Previous findings have also identified roles for IGF-1 
signaling in neuronal precursor proliferation and neuronal differentiation24, 53–56. Our results provide new insight 
into the molecular mechanisms underlying exercise-enhanced and IGF-1-driven hippocampal neurogenesis. The 
blunted neurogenic response of exercised RIT1−/− mice suggests that RIT1 participates in the transduction of 
running stimuli to promote enhanced hippocampal neurogenesis, whether in response to IGF-1 or another exer-
cise myokine57, 58. Not surprisingly, RIT1 deficiency does not result in a complete block of exercise-enhanced neu-
rogenesis (Fig. 1), as neurogenesis is controlled by a broad and sophisticated regulatory network6. Indeed, other 
Ras-related G-proteins are likely involved, as Ras-GRF2, a calcium-regulated exchange factor for Ras and Rac 
GTPases, has been found to contribute neurogenesis in response to enriched environment59. However, the failure 
of IGF-1 infusion to stimulate neuroblast proliferation in RIT1−/− mice suggests that RIT1 plays an essential role 
in IGF-1 dependent regulation of hippocampal neurogenesis, as other Ras family GTPases cannot compensate 
for RIT1 loss. While a number of studies have implicated elevated IGF-1 levels as a putative mediator of exercise 
induced neurogenesis15, 52, and our data would support a role for IGF-1/RIT1 in the benefits of exercise on brain 
Figure 4. RIT1 knockdown impairs IGF-1-dependent neural induction of HNPCs. (A) WT HNPC cultures 
were left untreated (-IGF1) or treated with IGF-1 (50 ng/ml, 24 h) following infection with either control (Cntl) 
or RIT1-RNAi lentivirus and co-immunostained with Tuj1 (white, pseudo color) and DAPI (nuclei; blue) (Scale 
bar 10 μm). (B) RIT1−/− HNPCs were transfected with or without Myc-tagged RIT1 and co-immunostained 
with Tuj1 (white, pseudocolor) and for nuclei (DAPI: blue) following vehicle or IGF-1 stimulation (50 ng/ml, 
24 h). (C,D) Quantification of Tuj1+ cells (n = 500 cells from 5–6 random fields) in HNPCs following either 
lentiviral-mediated RIT1 knockdown, or gene rescue in RIT1−/− HNPCs, with or without IGF-1 stimulation 
(*p < 0.05, one-way ANOVA). (E) RT-PCR analysis of lentiviral-mediated RIT1 RNAi silencing efficiency in 
HNPCs. RIT1#2 RNAi was used in all subsequent studies.
www.nature.com/scientificreports/
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plasticity, a growing literature suggests that a variety of factors beyond IGF-1 likely contribute to this process. 
Indeed, recent studies have identified the exercise myokine, cathepsin B (CTSB)58, as an important mediator of 
the neurogenic benefits of exercise, and additional peripheral blood factors have been shown to improve brain 
plasticity in aged animals57. Therefore, further studies are needed to determine whether RIT1, or other Ras family 
GTPases, contribute to these signaling pathways.
A growing literature supports a central role for Akt is the regulation of neuronal stem cell proliferation60, 61, 
including the control of exercise-mediated hippocampal neurogenesis28, 62 and IGF-1 signaling in neuronal stem 
cells22, 41, 63. Our observation that IGF-1-mediated ERK and Akt activity is blunted in RIT1−/− HNPC cultures 
(Fig. 2), but not following BDNF stimulation36, suggests that RIT1 deficiency might generate an IGF-1 selective, 
rather than global, defect in growth factor signaling within the HPNC niche. While these data implicate RIT1 as a 
key downstream regulator of neuronal IGF-1 signaling, the full contribution of RIT1 to IGF-1 signal transduction 
remains to be addressed, particularly details on how RIT1 deficiency impacts gene expression. In addition, it is 
important to identify the guanine nucleotide exchange factor(s) (GEF) involved in coupling IGF-1R activation to 
stimulation of neuronal RIT1 signaling. This is complicated by the fact that while activation of a SOS/Shc-Grb2 
complex has been associated with in vitro RIT1 activation following either NGF or PCAP stimulation of pheo-
chromocytoma cells, biochemical analysis has yet to identify a bona fide RIT1GEF. IGF-1 has been shown to be 
Figure 5. Role for RIT1 in IGF-1-dependent neuronal differentiation. (A,B) Representative confocal images of 
Ascl1 (red) and NeuroD1 (green) expression in WT HNPCs with or without IGF-1 (50 ng/ml, 24 h) stimulation. 
Scale bar, 20 μm. (C,D) Quantification (n = 200 cells from 5–6 fields) of Ascl1+ or NeuroD1+ neural precursor 
cells in WT HNPCs with or without IGF-1 stimulation (*p < 0.05, nonparametric one tailed t-test). (E,F) 
Representative confocal images of Ascl1+ (red) and NeuroD1+ (green) cells in RIT1−/− HNPCs or RIT1−/− 
HNPCs following re-expression of Myc-RIT1, with and without IGF-1 stimulation (50 ng/ml, 24 h). Scale bar, 
15 μm. (G,H) Quantification of Ascl1+ precursors (*p < 0.05, one-way ANOVA) and NeuroD1+ neuronal 
precursors (*p < 0.05, one-way ANOVA) following RIT1 complementation with or without IGF-1 stimulation. 
(I) Semi-quantitative RT-PCR demonstrates IGF-1-mediated increases in NeuroD1 and Ascl1 expression in 
RIT1−/− HNPCs following RIT1 complementation. Representative images of the gene bands were cropped from 
the original agarose gels. (J) Representative Western blot showing RIT1-dependent increase in Ascl1 protein 
following IGF-1 (20 ng/ml) stimulation of RIT1−/− HNPCs. Representative images of the protein bands were 
cropped from the original blots run in parallel. Results are presented as mean ± SEM calculated from three 
separate experiments.
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neuroprotective in models of traumatic brain injury64, 65, stroke and ischemic injury66, 67, preventing apoptotic 
death and promoting cell survival. As expression of active RIT1 has been shown to be neuroprotective in vitro37, 
studies are underway to determine activated RIT1 signaling is neuroprotective, capable of reducing behavioral 
deficits in the setting of brain trauma.
Sox2 is involved in the maintenance and proliferation of NPCs in vivo, neurosphere formation in vitro68, 69, 
and plays a key role in somatic cell reprogramming70–73. Furthermore, voluntary running is known to increase 
dividing Sox2+ HNPCs in the dentate gyrus leading to enhanced neurogenesis27. We find potentiation of Sox2 
transcriptional activity, stabilization of Sox2 protein levels, and increased proliferation and neural differenti-
ation of HNPCs following IGF-1 stimulation, suggesting that IGF-1/RIT1 regulation of Sox2 may represent a 
fundamental mechanism for controlling neurogenesis. IGF-1 has been shown to regulate Sox2 in a variety of 
systems, including human mesenchymal74 and colonic stem cells75. Thus, it is possible that IGF-1/RIT1 signal-
ing might regulate Sox2 activity in diverse cell populations. We present data indicating that Akt is required for 
IGF1/RIT1-dependent Sox2 activity. This extends recent studies showing that Akt signaling contributes to the 
Figure 6. RIT1 contributes to IGF-1-mediated Sox2 stabilization and transcriptional activation. (A) 
Representative confocal images of Sox2+ cells from WT HNPC cultures left untreated (-IGF1) or treated with 
IGF-1 (50 ng/ml; 24 h) (Scale bar, 15 μm) following infection with either control (Cntl) or RIT1-directed RNAi 
(RIT1#2) and co-immunostained with Nestin (green) and Sox2 (red). The arrowheads (white) indicate HNPCs 
that express Sox2. (B) Representative micrographs of Sox2 expression in RIT1−/− HNPCs, with and without re-
expression of Myc-RIT1 following IGF-1 (50 ng/ml; 24 h) stimulation (Scale bar 15 μm). (C) Immunoblotting 
for SOX2 in WT HNPCs with or without stimulation with IGF-1 (50 ng/ml; 24 h). Representative images were 
cropped from the original blots run in parallel. (D) Immunoblotting for SOX2 levels in RIT1−/− HNPCs in the 
presence of transiently transfected Myc-RIT1 and IGF-1 stimulation (50 ng/ml; 24 h). Representative images 
were cropped from the original blots run in parallel. (E,F) Quantification (fold-change) of Sox2+ cells in the 
indicated HNPC cultures following IGF-1 stimulation (50 ng/ml; 24 h) are presented as mean ± SEM (*p < 0.05, 
one-way ANOVA). (G,H) Quantification of Sox2 luciferase reporter activity in cultured WT, RIT1−/−, or 
RIT1−/− HNPCs following Myc-RIT1 complementation, with or without IGF-1 stimulation (50 ng/ml, 24 h) are 
presented as mean ± SEM from three separate experiments (*p < 0.01, one-way ANOVA).
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regulation of embryonic stem cell fate by controlling Sox2 stabilization and transcriptional activity by a phos-
phorylation at threonine 118 (T118)47. Consistent with a conserved regulatory mechanism, we find that IGF-1 
stimulates Sox2 T118 phosphorylation in HNPCs, resulting in higher levels of Sox2 T118+ nuclei (Figs 6 and 8). 
Using RIT1−/− HNPCs, RNAi methods, and pharmacological Akt inhibition, we demonstrate that RIT1 and Akt 
are required for IGF-mediated Sox2 transcriptional activation and neuronal differentiation (Figs 6–8). Following 
traumatic brain injury we have shown that conditional overexpression of IGF-1 leads to increased hippocampal 
neurogenesis64, 76, while post-TBI neurogenesis is delayed in RIT1−/− mice36. Whether these changes rely upon 
changes in Sox2 function remains to be determined.
Interestingly, there is a growing literature suggesting that IGF-1 is critical for malignant transformation and 
metastasis of cancer cells77–79, and that Sox2 controls tumor initiation and cancer stem-cell function80, 81. We have 
found that conditional RIT1 overexpression in the dentate gyrus leads to the robust generation of neuroblasts39. 
Recently, we also identified RIT1 as a novel driver oncogene in a subset of human lung adenocarcinomas, and our 
data suggest PI3K/Akt inhibition as a potential therapeutic strategy in RIT1-mutated tumors38. Studies are under-
way to determine whether oncogenic RIT1-dependent tumorigenesis involves activation of Akt-Sox2 signaling.
In summary, we demonstrate a key role for the Ras-related GTPase, RIT1, in both IGF-1 and exercise-induced 
neurogenesis. IGF-1 dependent NPC proliferation and neural differentiation are inhibited by genetic deletion of 
the RIT1 gene. We also present data that provides new insight into the mechanisms underlying IGF-1-directed 
neurogenesis. Our findings reveal that a previously uncharacterized IGF-1/RIT1/Akt/Sox2 signaling cascade 
Figure 7. RIT1 contributes to IGF-1-mediated Akt activation. (A,B) Representative confocal images of 
WT, RIT1−/−, or RIT1−/− HNPCs completed by re-expression with Myc-RIT1. HNPC cultures were co-
immunostained for phospho-Akt S473 (green) and Nestin (red) following vehicle or IGF-1 stimulation (50 ng/
ml; 24 h). Scale bar, 20 μm. (C,D) Quantification of phospho-Akt S473 levels following IGF-1 stimulation of the 
indicated HNPC cultures is presented as mean ± SEM calculated from three separate experiments (*p < 0.01, 
nonparametric one tailed t-test).
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is import for regulating the proliferation and differentiation of neural precursors within the dentate gyrus. 
Collectively, these data provide new insight into mechanisms by which IGF-1 signaling and Sox2 function in 
neural stem-cell maintenance, embryogenesis and neuronal development.
Materials and Methods
Mouse running and BrdU labeling. RIT1−/− mice have been previously described36. 12-week-old male 
RIT1−/− mice and their WT littermates were divided into 2 groups and randomly placed in standard-sized 
rat cages (6 mice per cage) with (running group) or without (sedentary group) 2 (6 inch) running wheels82. 
Wheel running activity for each genotype was monitored 24 h/day and 7 days/week using ClockLab software 
(Actimetrics, Inc). For lineage labeling experiments, each mouse independent of housing was intraperitoneally 
(i.p.) injected with BrdU (50 mg/kg, in 0.9% Saline) once daily for the first 14 days of the experiment. Newborn 
immature neuron assessment was performed 2 days after the last BrdU injection (day 16). Neural maturation was 
quantified 1 month after the last BrdU injection (day 42). Following the either length of housing (16 or 42 days) 
mice were anesthetized with sodium pentobarbital (65 mg/kg, i.p.), transcardially perfused with heparinized 
Figure 8. IGF-1-dependent Sox2 phosphorylation relies on RIT1-Akt signaling. (A) Immunoblotting for levels 
of Sox2 phospho-Ser250/Ser251 and SOX2 phospho-T118 with and without IGF-1 stimulation (50 ng/ml; 
24 h). Representative images were cropped from the original blots run in parallel. (B,C) Representative confocal 
images of phospho-Sox2 T118+ nuclei in WT, RIT1−/−, or RIT1−/− HNPCs complemented by re-expression of 
Myc-RIT1 left untreated (-IGF-1) or 24 h after stimulation with IGF-1 (50 ng/ml) or co-stimulated with IGF-1 
and the Akt inhibitor Triciribine (3 µM Trib.) and immunostained for phospho-Sox2 T118 (green) and Nestin 
(red). Scale bar, 20 μm. (D,E) Quantification of Nestin+/Sox2 T118+ cells following IGF-1 stimulation of WT 
HNPCs with or without Akt inhibition (1–4 uM Trib.) (*p < 0.05, one-way ANOVA) or IGF-1 stimulation of 
RIT1−/− HNPCs with or without RIT1 complementation (*p < 0.05, nonparametric one tailed t-test) (≥200 
cells counted from 5–6 fields). (F) Representative confocal images of HNPCs co-immunostained for Tuj1+ 
(green) and DAPI (nuclei, blue) following IGF-1 (50 ng/ml) stimulation with or without Akt inhibition (1–4 uM 
Trib.). (G) Quantification of Tuj1+ neurons in WT HNPCs following IGF-1 stimulation (50 ng/ml) ± Triciribine 
(3 μM) (≥500 cells from 5–6 fields) (*p < 0.05, nonparametric t-test). Data are presented as mean ± SEM 
calculated from three separate experiments. (H) Schematic diagram of the putative IGF-1/RIT1/Akt/Sox2 signal 
transduction cascade. The sites of pharmacological inhibition (⊥) and the target of shRNA silencing reagents 
(•) are indicated.
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saline followed by 10% buffered formalin, and decapitated. After 24 h of post-fixation in 10% buffered formalin, 
brains were removed from the skull, post-fixed for an additional 24 h, cryoprotected in 30% sucrose, and quickly 
frozen in isopentane. Serial coronal 40 µm sections were cut using a freezing sliding microtome (Dolby-Jamison). 
Every tenth section (400 µm intervals between sections) was selected as a set for further analysis. All experimen-
tal procedures were approved by the University of Kentucky Institutional Animal Care and Use Committee in 
accordance with guidelines established by the National Institutes of Health in the Guide for the Care and Use of 
Laboratory Animals. Animals were housed at up to 5 mice per cage in the University of Kentucky Medical Center 
vivarium with a 14:10-hour light/dark photoperiod and were provided food and water ad libitum.
Subcutaneous IGF-1 infusion. Osmotic pumps (ALZET) were filled aseptically with 0.2-µm-filter ster-
ilized saline or rIGF-1 (National Hormone and Peptide Program, Torrance, CA). 12-week-old RIT1−/− mice 
(n = 25) and their wild-type littermates were randomly divided into 2 groups (IGF-1 or control), anesthetized 
with isoflurane, and implanted subcutaneously dorsally16 for 7 days. The infusion rate of rIGF-1 was 500 ng/kg/
day. At day 3 of infusion, mice were i.p. injected with BrdU (50 mg/kg) at 3 h intervals for 12 h.
Hippocampal neuronal stem cell (HNPC) cultures. Primary HNPC cultures were prepared as 
describe39. HNPCs were isolated from wild-type and RIT1−/− mice as described83. Briefly, mice were euthanized, 
the brain dissected and placed in immersion buffer (HBSS (1x) with no Ca2+ or Mg2+ containing 1x antibiotic 
solution (Gibco)). Using a stereomicroscope, dentate gyrus (DG) from hippocampi were dissected and placed 
in ice-cold immersion buffer. DG (4–5/genotype) were washed with HBSS (1x) containing antibiotic, incubated 
at 37 °C for 30–45 min with frequent shaking in enzymatic digestion solution (0.25% trypsin in 1 × HBSS with 
activated papain), trypsin activity was quenched by repeated washing with DMEM (5–10 ml), and placed in 
37 °C culture medium (containing DMEM/F12 (1:1), supplemented with 0.3% B27 without insulin, 20 ng/ml of 
EGF and 10 ng/ml bFGF, and antibiotics). HNPCs were released by trituration (3–4 times) into single cells using 
fire polished Pasteur pipettes. Approximately, 50 × 104 cells were plated in 12 well plates for suspension culture. 
Neurospheres were evident by day 3. For passage, neurospheres were pooled and mechanically dissociated into 
single cells and seeded into suspension in growth media in presence of EGF and bFGF (see above). For immu-
nocytochemistry and immunoblotting, single cell suspensions derived from neurospheres were plated on poly 
D-Lysine coated coverslips or 6 well plates. HNPCs used in this study were Nestin+ (HNPC lineage) and >2 
passages which promotes homogeneity in the cell population.
RNAi-mediated silencing in HNPCs. Lentiviral vector pZIP-mCMV containing the RIT1 pri-shRNA 
sequence ( TG CT GTTG A CA GTGAGCGACACGAAGTTCGGGAGTTTAAATAGTGAAGCCACAGATGTA
TTTAAACTCCCGAACTTCGTGGTGCCTACTGCCTCGGA) was purchased from transOMIC Technologies 
(Huntsville, AL). Lentivirus was generated in 293LTV cells using the packaging vectors PsPAX2 and pMD2.G 
(Univ. Kentucky Genetic Technology Core). The efficiency of RNAi silencing in HNPCs was determined to be 
>70% using RT-PCR and confocal microscopy. Briefly, HNPCs after passage were allowed to assume normal 
morphology for 24–48 h before RNAi silencing. Growth medium was removed and stored as per our previously 
described method84, 1 µl of polybrene (Santa Cruz Biotechnology) was added in 1x HBSS for 10 min at 37 °C 
followed by repeated washes in 1x DPBS. Growth medium was premixed with 3 MOIs of either non-targeting 
control or RIT1-RNAi expressing lentivirus and placed on cells for 4–12 h at 37 °C. Cells were allowed to recover 
in fresh growth medium for 48–72 h to permit RIT1 silencing.
Cell transfection and neuronal differentiation. For HNPC transfection, fresh neurospheres were dis-
sociated and approximately 105 cells were plated on poly-D-lysine coated coverslips/6 well plates. Cells were 
transfected 72 h after plating, using Jetprime transection reagent85 according to the manufacturer’s protocol, and 
allowed to recover cells 48 h before analysis. For IGF-1 stimulation of HNPCs, DMEM was supplemented with 
F12 (1:1) and FGF2 (10 ng/ml). For HNPC neuronal differentiation analysis, cells were placed in Neurobasal 
medium containing 1% FBS and RA (1 µM) for 4–6 days.
Immunofluorescence. Immunofluorescence or immunocytochemistry was performed as per our previ-
ously published method84. Mice were anesthetized with sodium pentobarbital (65 mg/kg, i.p.), transcardially 
perfused with 0.98% saline followed by 4% paraformaldehyde, and decapitated84. Brains were removed from the 
skull, subject to post-fixation (2–3 days) at 4 °C in 4% paraformaldehyde, subject to increasing concentrations 
of sucrose (10–30%: O/N for each 10% step), and dissected under a stereomicroscope for hippocampus. Tissue 
blocks were embedded in OCT and snap frozen. All the blocks were stored at −80 °C for at least 2 days before 
coronal sections (15 µM or 40 µM) were cut using a cryostat, and mounted on superfrost plus slides (Fisher). 
Antigen retrieval was performed in citrate pH 6.2. For BrdU, antigen retrieval was performed with warm trypsin 
(0.25%) containing 2N HCl for 5 min at RT. The sections were extensively washed with PBS and incubated in 
blocking and permeablizing buffer [1% serum (matching the secondary antibody host), 1% Triton X-100 in 
1 × PBS) for 10 min at RT followed by extensive washing (4 × PBS). After blocking, primary antibodies were 
diluted in blocking buffer (0.01 M PBS pH 7.2 containing 1% serum, 0.05% Tween 20 and 0.1% Triton X-100) 
and applied to the sections O/N (4 °C). Dilutions were: rabbit anti-DCX (1:500); NeuN (1:3000), Rat anti-BrdU 
(Sigma, 1:800), Sox2 (Abcam, 1:300), Goat NeuroD1 (Santa Cruz, 1:200), Rabbit Nestin (Covance, 1:300), Rabbit 
Aktp473 (Cell Signaling Technology, 1:400) and Mouse Sox2pT118 (ECM Biosciences, 1:200). On the following 
day, sections were washed with 1 × PBS (x4) and secondary antibody (goat-anti-rabbit IgG FTIC: 1:1,000; either 
conjugated with Alexa 488, Alexa 568, Alexa 594 or PE) diluted in blocking buffer was applied for 2 h in the dark. 
Sections were then washed with 1 × PBS (x4), air dried, and cover slipped with SlowFade Gold containing DAPI. 
For immunocytochemistry, cells were fixed in 4% paraformaldehyde for 15 minutes at RT, permeablized, and 
blocked as described for tissue sections. Representative images were captured using a Nikon CKX31 A1 confocal 
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microscope or Nikon C2 confocal microscope. All images were acquired using the NIS Elements software pack-
age (University of Kentucky License).
Image acquisition and analysis. Analysis was performed as previously described86. Briefly, isotype control 
slides were mounted to nullify nonspecific signals from either the Nikon C2 confocal or Nikon A2 confocal prior 
to mounting non-primary antibody treated slides and channels were adjusted to the individual secondary fluoro-
phore. The numerical aperture and intensity values were optimized to minimize oversaturation and the channel 
data, pin hole details were recorded, and images recorded at 1024 pixels and 16x speed (Nikon C2 Confocal). 
Groups of images (3–6 images per specimen) were analyzed using ImageJ. For example, alternate color masks 
were applied to determine double positive (Nestin+/Ki67+) or single positive (Nestin+ only) for ≥200 nuclei from 
5–6 random fields (for normalization), and data converted to relative fold changes. A similar approach was used 
to determine neuronal differentiation and the number Sox2+ and Sox T118+ HNPCs. For Akt activation follow-
ing IGF-1 stimulation, the intensity profile of ≥50 cells from 15 random fields were normalized to DAPI using 
ImageJ. The mean was determined from 5–8 images per group. Quantification of immature (DCX+/BrdU+) and 
mature neuron analysis (NeuN+/BrdU+) was performed as previously described36. Briefly, to quantify the fluores-
cently labeled cells in the dentate gyrus, three sections (pre-epicenter, epicenter, post-epicenter, 400 μm intervals) 
were counted using a Nikon Eclipse E600 fluorescence microscope (40× objective). The focal plane was moved 
throughout the z-axis to capture each positive cell. To estimate the volume of the dentate gyrus, images were 
collected using a Zeiss Axiovert 200 M fluorescence microscope (10× objective). The volume of the dentate gyrus 
was then calculated by multiplying the area of the dentate gyrus measured using ImageJ (NIH) by the thickness 
of each section (40 μm). Cell density was obtained by dividing total cell counts by the total volume of the dentate 
gyrus for the three sections that were counted.
Western blotting. Tissues/cells were homogenized using a Next Advance Bullet Blender at 4 °C in lysis 
buffer (20 mM Tris·HCl pH 7.5, 250 mM NaCl, 10 mM MgCl2, 1% Triton X-100, 1 mM Na3VO4, 50 mM 
β-glycerophosphate, 1x protease inhibitor cocktail). Whole cell lysates were resolved on SDS-PAGE gels, trans-
ferred to nitrocellulose membranes (12 h, 0.08 mA), and protein abundance and phosphorylation determined 
by immunoblotting with the appropriate phospho-specific antibodies and band intensity quantified using a 
ChemiDoc MP with Image Lab software (Bio-Rad)35, 36.
Luciferase gene reporter assay. Cignal Sox2 luciferase reporter was obtained from Qiagen (CCS-0038L). 
HNPCs were transfected with reporter and transduced with RNAi (Control RNAi or RIT1 RNAi), while RIT1−/− 
HNPCs were co-transfected with the reporter and Myc-RIT1 (as indicated) or empty vector, and stimulated with/
without IGF-1 (50 ng/ml, 24 h) in presence of FGF2 (10 ng/mL). Cells were washed with PBS and luciferase activ-
ity determined using a firefly luciferase assay kit (Promega) after passive lysis as described39.
Statistical analysis. The data is presented as Mean ± SEM. Statistical analysis was carried out by either one 
way/two way ANNOVA combined with post hoc analysis using Tukey Kramer multiple comparisons or nonpara-
metric unpaired one tailed t-test. Significance reported in this manuscript is p < 0.05. Any changes with p > 0.05 
were considered to be insignificant.
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